Foghorn Therapeutics Inc. · NASDAQ:FHTX
BVF PARTNERS L P/IL reported a 14.30% stake in Foghorn Therapeutics Inc. (Schedule 13G/A)
Event Oct 1, 2026 · Filed Oct 5, 2026
BVF PARTNERS L P/IL reported a 14.30% stake in Foghorn Therapeutics Inc., 8,507,000 shares, as a passive investor on Oct 1, 2026. Filed Oct 5, 2026 (Schedule 13G/A).
- Stake
- 14.30%
- Shares
- 8,507,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 7.60% | 4,494,462 |
| BVF I GP LLC | 7.60% | 4,494,462 |
| BIOTECHNOLOGY VALUE FUND II LP | 5.40% | 3,232,448 |
| BVF II GP LLC | 5.40% | 3,232,448 |
| Biotechnology Value Trading Fund OS LP | 1.00% | 619,258 |
| BVF Partners OS Ltd. | 1.00% | 619,258 |
| BVF GP HOLDINGS LLC | 13.00% | 7,726,910 |
| BVF PARTNERS L P/IL | 14.30% | 8,507,000 |
| BVF INC/IL | 14.30% | 8,507,000 |
| LAMPERT MARK N | 14.30% | 8,507,000 |
Source
Related
- Foghorn Therapeutics Inc.
- Bvf Partners L P
- Foghorn Therapeutics Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · May 15, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · May 14, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Form 4 · Gottschalk Adrian · Apr 13, 2026
- Schedule 13D/A · Flagship Ventures Fund V, L.P. · Jan 13, 2026
- Schedule 13G/A · FMR LLC · Feb 12, 2025